[Hepatotoxic action of furosemide in experimental liver cirrhosis].
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D004128:Dimethylnitrosamine; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D005665:Furosemide / Q000627:therapeutic use / Q000633:toxicity*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood
D005665:Furosemide; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D004128:Dimethylnitrosamine
L'action hépatotoxique du fourosémide dans la cirrhose hépatique expérimentale.